Cited by 710Cardiovascular Effects of ExerciseCardiomyopathy and Myosin StudiesCardiac electrophysiology and arrhythmias

Exercise Increases Age-Related Penetrance and Arrhythmic Risk in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy–Associated Desmosomal Mutation Carriers

Open access
James, Cynthia A., Bhonsale, Aditya, Tichnell, Crystal, Murray, Brittney, Russell, Stuart D., Tandri, Harikrishna, Tedford, Ryan J., Judge, Daniel P. +1 more·2013·Journal of the American College of Cardiology

Abstract

Objectives This study sought to determine how exercise influences penetrance of arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) among patients with desmosomal mutations. Background Although animal models and anecdotal evidence suggest that exercise is a risk factor for ARVD/C, there have been no systematic human studies. Methods Eighty-seven carriers (46 male; mean age, 44 ± 18 years) were interviewed about regular physical activity from 10 years of age. The relationship of exercise with sustained ventricular arrhythmia (ventricular tachycardia/ventricular fibrillation [VT/VF]), stage C heart failure (HF), and meeting diagnostic criteria for ARVD/C (2010 Revised Task Force Criteria [TFC]) was studied. Results Symptoms developed in endurance athletes (N = 56) at a younger age (30.1 ± 13.0 years vs. 40.6 ± 21.1 years, p = 0.05); they were more likely to meet TFC at last follow-up (82% vs. 35%, p < 0.001) and have a lower lifetime survival free of VT/VF (p = 0.013) and HF (p = 0.004). Compared with those who did the least exercise per year (lowest quartile) before presentation, those in the second (odds ratio [OR]: 6.64, p = 0.013), third (OR: 16.7, p = 0.001), and top (OR: 25.3, p < 0.0001) quartiles were increasingly likely to meet TFC. Among 61 individuals who did not present with VT/VF, the 13 subjects experiencing a first VT/VF event over a mean follow-up of 8.4 ± 6.7 years were all endurance athletes (p = 0.002). Survival from a first VT/VF event was lowest among those who exercised most (top quartile) both before (p = 0.036) and after (p = 0.005) clinical presentation. Among individuals in the top quartile, a reduction in exercise decreased VT/VF risk (p = 0.04). Conclusions Endurance exercise and frequent exercise increase the risk of VT/VF, HF, and ARVD/C in desmosomal mutation carriers. These findings support exercise restriction for these patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2013.06.033

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Environmental modifiers such as endurance exercise, psychological stress, diet, alcohol, and metabolic dysregulation influence ACM disease penetrance and progression, in part through modulation of inflammatory processes.

    “environmental modifiers such as endurance exercise [24,25,26,27,28,29,30], psychological stress [31,32,33], diet [34,35], alcohol [36], and metabolic dysregulation [37,38,39] have been shown to influence disease penetrance and progression, in part, through modulation of inflammatory processes.”

    From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [26]

    The Discussion sections on clinical course and the relationship between exercise and ARVD/C report that endurance exercise is associated with greater disease penetrance and worse outcomes in desmosomal mutation carriers. The proposed inflammatory mechanism is less certain: the paper says exercise “may facilitate” myocyte uncoupling leading to inflammation, rather than showing that modulation of inflammation mediates those outcomes. This citation is attached to endurance exercise, not the other modifiers listed in the sentence. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. [1]Marcus F Fontaine G Guiraudon G Right ventricular dysplasia: a report of 24 adult cases Circulation 1982 65 384 98 7053899
  2. [2]Fontaine G Arrhythmogenic right ventricular dysplasia Curr Opin Cardiol 1995 10 16 20 7787258
  3. [3]Basso C Corrado D Marcus FI Nava A Thiene G Arrhythmogenic right ventricular cardiomyopathy Lancet 2009 373 1289 1300 19362677
  4. [4]Dalal D Nasir K Bomma C Arrhythmogenic right ventricular dysplasia Circulation 2005 112 3823 32 16344387
  5. [5]Sen-Chowdhry S Morgan RD Chambers JC McKenna WJ Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment Annu Rev Med 2010 61 233 53 20059337
  6. [7]Maron BJ Ackerman MJ Nishimura RA Pyeritz RE Towbin JA Udelson JE Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome J Am Coll Cardiol 2005 45 1340 5 15837284
  7. [9]Gerull B Heuser A Wichter T Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy Nat Genet 2004 36 1162 4 15489853
  8. [10]Awad MM Dalal D Cho E DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy Am J Hum Genet 2006 79 136 42 16773573 PMC1474134
  9. [11]Rampazzo A Nava A Malacrida S Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy Am J Hum Genet 2002 71 1200 6 12373648 PMC385098
  10. [12]McKoy G Protonotarios N Crosby A Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) Lancet 2000 355 2119 24 10902626
  11. [13]Syrris P Ward D Evans A Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2 Am J Hum Genet 2006 79 978 84 17033975 PMC1698574
  12. [14]den Haan AD Tan BY Zikusoka MN Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy Circ Cardiovasc Genet 2009 2 5 428 35 20031617 PMC2801867
  13. [15]Cox MGPJ van der Zwaag PA van der Werf C Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening Circulation 2011 123 2690 700 21606396
  14. [16]Saffitz JE Asimaki A Huang H Arrhythmogenic right ventricular cardiomyopathy: new insights into mechanisms of disease Cardiovascular Pathology 2010 19 166 70 20051321
  15. [17]Delmar M McKenna WJ The cardiac desmosome and arrhythmogenic cardiomyopathies from gene to disease Circ Res 2010 107 700 14 20847325
  16. [18]Kirchhof P Fabritz L Zwiener M Age-and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice Circulation 2006 114 1799 806 17030684
  17. [19]Ackerman MJ Priori SG Willems S HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies Europace 2011 13 1077 109 21810866
  18. [20]Dalal D James C Devanagondi R Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 2006 48 1416 24 17010805
  19. [21]Quarta G Muir A Pantazis A Familial evaluation in arrhythmogenic right ventricular cardiomyopathy Circulation 2011 123 2701 9 21606390
  20. [22]Hunt SA Baker DW Chin MH ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult J Am Coll Cardiol 2001 38 2101 13 11738322
  21. [23]Tedford RJ James C Judge DP Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Col Cardiol 2012 59 289 290 PMC3258430 22240135
  22. [24]Marcus FI McKenna WJ Sherrill D Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia proposed modification of the task force criteria Eu Heart J 2010 31 806 14 PMC2848326 20172912
  23. [25]Turkbey EB Jorgensen NW Johnson W Physical activity and physiological cardiac remodelling in a community setting: the Multi-Ethnic Study of Atherosclerosis (MESA) Heart 2010 96 42 8 19858139 PMC3037117
  24. [26]Mitchell JH Haskell W Snell P Van Camp SP Task Force 8: Classification of sports J Am Coll Cardiol 2005 45 1364 7 15837288
  25. [27]Thiene G Nava A Corrado D Rossi L Pennelli N Right ventricular cardiomyopathy and sudden death in young people N Engl J Med 1988 318 129 33 3336399
  26. [28]Corrado D Basso C Pavei A Michieli P Schiavon M Thiene G Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program JAMA 2006 296 1593 601 17018804

Cited by

Sorted by citations

Authors
James, C. A., Bhonsale, A., Tichnell, C., Murray, B., Russell, S. D., Tandri, H., Tedford, R. J., Judge, D. P., & Calkins, H.
Affiliations
Johns Hopkins University (US)
Corresponding author
James, Cynthia A.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2013-10
Volume
62
Issue
14
Pages
1290-1297
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2089109470
Cited by
710
References
4
Citations by year
2026: 41 · 2025: 57 · 2024: 47 · 2023: 47 · 2022: 62 · 2021: 64 · 2020: 73 · 2019: 53 · 2018: 56 · 2017: 73 · 2016: 43 · 2015: 50 · 2014: 37 · 2013: 6
FWCI
30.84
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Bogle Foundation, the Healing Hearts Foundation, the Campanella family, Wilmerding Endowments
  • Dr. Francis P. Chiaramonte Private Foundation
  • National Heart, Lung, and Blood Institute (K23HL093350)
  • Medtronic and St. Jude Medical
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
desmosomal mutations, physical activity, endurance athletes, ventricular arrhythmias, ventricular tachycardia, ventricular fibrillation, penetrance, heart failure, survival, age of onset, genetic carriers, sudden cardiac death
MeSH terms
Adult, Arrhythmias, Cardiac, Desmosomes, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Mutation, Prospective Studies, Risk Factors, Exercise, Arrhythmogenic Right Ventricular Dysplasia, Penetrance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review